ACTRN12618000099224终止未知
An investigator initiated, prospective, randomised controlled trial to assess the efficacy of using the injection site desensitiser device Coolsense (R) on pain and anxiety in Australian adult Blood Donors - Part 2
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Feasibility and Efficacy of using a non-invasive pain numbing device in Australian Blood Donor Centres - Part 1Blood DonationACTRN12617000950369Australian Red Cross Blood Service50
已完成
不适用
Prospective, randomized, controlled, Investigator Initiated Study to investigate Efficacy and Safety of cell-free Autologous Conditioned Serum (ACS) alone or in combination with hyaluronic acid (HA) in reduced facial skin elasticity by womareduce of facial skin elasticity in healthy volunteersDRKS00011249niversität Hamburg Fachrichtung Kosmetikwissenschaft42
已完成
4 期
An Investigator Initiated, Controlled, Prospective, Non-Inferiority, Parallel-Group, randomised, Interventional, Open, Blinded Outcome Assessment (PROBE-Design), Multi-centre Trial, Comparing Efficacy and Safety of Isolation of the Pulmonary Veins with a Cryoballoon Catheter Versus a Radiofrequency Ablation with a ThermoCool Catheter in Patients with Paroxysmal Atrial FibrillatioParoxysmal atrial fibrillationirregular heart beat10007521NL-OMON39146FGK Representative Service GmbH114
终止
4 期
Pilot phase for the Tension-type HeadAche Prevention Project (HAPPy Too) to investigate in a double-blind, randomised trial whether treatment with low-dose blood pressure (BP) lowering therapy on top of standard care will reduce tension-type headache compared to placebo and standard care.Tension-type HeadacheACTRN12617001323314The George Institute for Global Health120
终止
4 期
Pilot phase for the workplace migraine HeadAche Prevention Project (HAPPy - pilot) to investigate in a double blind randomised factorial trial whether treatment with low-dose combination blood pressure (BP) and cholesterol lowering therapy will reduce migraine compared to standard therapy and placebo.Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)MigraineACTRN12616000937415The George Institute for Global Health180